|
2025 Journal Article An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancerRuan, Qi, Chen, Tao, Kim, Minwoo, Yang, Haotian, Sinha, Debottam, He, Yaowu, Burke, Lez, Wickramasuriya, Lashith, Cao, Lu, Yan, Weikang, Hooper, John, Wang, Haolu, Bridle, Kim, Chandra, Janin, Crawford, Darrell and Liang, Xiaowen (2025). An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer. Hepatology PMID 8302946. doi: 10.1097/hep.0000000000001639 |
